IHH Healthcare Valuation Multiples

IHH Healthcare is valued at $17B as of October 2026, a 3.1x revenue multiple. In the last 12 months, IHH Healthcare revenue was $6.9B and IHH Healthcare EBITDA was $1.5B.

IHH Healthcare Overview

About IHH Healthcare

IHH Healthcare Bhd operates a network of healthcare clinics, hospitals, and postoperative rehabilitation centers. It also provides ancillary services, which include diagnostic laboratories, imaging centers, ambulatory care, and medical education facilities. The group’s reportable segments include Hospital and healthcare, Labs, PLife REIT, and Others. A majority of its revenue is generated from the Hospital and healthcare segment, which represents income generated from the provision of healthcare services through its hospitals and healthcare clinics across Singapore, Malaysia, India, Greater China, Turkiye and Europe, and Southeast Asia. Geographically, the group derives maximum revenue from Turkiye and Europe.


Founded

2010

HQ

Malaysia

Employees

70.0K

Financials (LTM)

Revenue: $6.9B
EBITDA: $1.5B

EV

$21B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

IHH Healthcare Financials

IHH Healthcare reported last 12-month revenue of $6.9B and EBITDA of $1.5B.

In the same LTM period, IHH Healthcare generated $4.9B in gross profit, $1.5B in EBITDA, and $556M in net income.

Revenue (LTM)


IHH Healthcare P&L

In the most recent fiscal year, IHH Healthcare reported revenue of $6.3B and EBITDA of $1.5B.

IHH Healthcare is profitable as of last fiscal year, with gross margin of 72%, EBITDA margin of 24%, and net margin of 8%.

See analyst estimates for IHH Healthcare
LTMLast FY202320242025202620272028
Revenue$6.9B$6.3B$5.1B$6B$6.3B
Gross Profit$4.9B$4.5B$3.6B$4.3B$4.5B
Gross Margin71%72%70%72%72%
EBITDA$1.5B$1.5B$1.5B$1.5B$1.5B
EBITDA Margin22%24%29%25%24%
EBIT Margin15%15%20%16%15%
Net Profit$556M$515M$726M$653M$515M
Net Margin8%8%14%11%8%
Net Debt-$2.9B---

Financial data powered by Morningstar, Inc.

IHH Healthcare Stock Performance

IHH Healthcare has current market cap of $17B, and enterprise value of $21B.

Market Cap Evolution


IHH Healthcare's stock price is $1.94.

IHH Healthcare share price increased by 1.0% in the last 30 days, and decreased by 1.5% in the last year.

IHH Healthcare has an EPS (earnings per share) of $0.06.

See more trading valuation data for IHH Healthcare
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$21B$17B0.1%1.0%-5.2%-1.5%$0.06

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

IHH Healthcare Valuation Multiples

IHH Healthcare trades at 3.1x EV/Revenue multiple, and 14.0x EV/EBITDA.

See NTM and 2027E valuation multiples for IHH Healthcare

EV / Revenue (LTM)


IHH Healthcare Financial Valuation Multiples

As of October 21, 2026, IHH Healthcare has market cap of $17B and EV of $21B.

IHH Healthcare has a P/E ratio of 30.8x.

LTMLast FY202320242025202620272028
EV/Revenue3.1x3.4x4.1x3.6x3.4x
EV/EBITDA14.0x14.2x14.1x14.1x14.2x
EV/EBIT20.8x22.3x20.4x22.2x22.3x
EV/Gross Profit4.3x4.7x5.9x4.9x4.7x
P/E30.8x33.3x23.6x26.2x33.3x
EV/FCF27.3x72.7x64.1x162.5x72.7x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified IHH Healthcare Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

IHH Healthcare Margins & Growth Rates

IHH Healthcare grew revenue by 10% and EBITDA by 2% in the last fiscal year.

In the most recent fiscal year, IHH Healthcare reported gross margin of 72%, EBITDA margin of 24%, and net margin of 8%.

See estimated margins and future growth rates for IHH Healthcare

IHH Healthcare Margins

Last FY202420252026202720282029
Gross Margin72%72%72%71%
EBITDA Margin24%25%24%22%
EBIT Margin15%16%15%15%
Net Margin8%11%8%8%
FCF Margin5%2%5%12%

IHH Healthcare Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth10%16%5%10%
Gross Profit Growth10%20%5%10%
EBITDA Growth2%0%(1%)2%
EBIT Growth8%(8%)(0%)8%
Net Profit Growth9%(10%)(21%)9%
FCF Growth182%(61%)123%182%

Data powered by FactSet, Inc. and Morningstar, Inc.

IHH Healthcare Operational KPIs

IHH Healthcare's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.

IHH Healthcare's Rule of 40 is 32% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

IHH Healthcare's Rule of X is 47% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for IHH Healthcare
LTMLast FY202320242025202620272028
Rule of 4031%32%---
Bessemer Rule of X45%47%---
Revenue per Employee-$0.1M---
Opex per Employee-$0.1M---
Opex to Revenue-57%50%56%57%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

IHH Healthcare Competitors

IHH Healthcare competitors include Rede D'Or São Luiz, Dr. Sulaiman Al Habib, Tenet Healthcare, Encompass Health, Apollo Hospitals, DaVita, Aier EYE Hospital Group, Universal Health Services, Bradsaúde and Bangkok Dusit Medical Services.

Most IHH Healthcare public comparables operate across Hospitals & Clinics.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Rede D'Or São Luiz$11B$1.3B2.0x1.8x16.5x9.5x
Dr. Sulaiman Al Habib$3.7B$927M6.2x5.6x24.3x23.5x
Tenet Healthcare$21B$4.5B1.7x1.7x8.3x7.6x
Encompass Health$5.9B$1.4B2.6x2.5x11.1x11.5x
Apollo Hospitals$2.6B$403M4.7x4.3x30.9x28.0x
DaVita$14B$2.6B1.9x1.8x9.7x8.9x
Aier EYE Hospital Group$3.3B$959M3.4x3.3x11.9x11.7x
Universal Health Services$17B$2.7B0.9x0.9x5.9x6.2x

This data is available for Pro users. Sign up to see all IHH Healthcare competitors and their valuation data.

Start Free Trial

IHH Healthcare VC Funding History

Before going public, IHH Healthcare raised funding across 1 round.

Last private valuation of IHH Healthcare was $636M, after raising a round in May 2008 from Khazanah Nasional.


IHH Healthcare Funding Rounds

DateStageInvestorsRaisedValuationRev. MultipleDeal Summary
May-08SecondaryKhazanah Nasional-$636MKhazanah Nasional made a direct equity investment in Parkway Holdings in 2008. The source describes the relevant interest as approximately 22.8%. The disclosed transaction figure was SGD 865 million; the structured amount field records it as transaction value and does not imply that it was solely the investor's cheque. Parkway Holdings is a Singapore-based private hospital and healthcare group that later became part of IHH Healthcare. The organisation serves customers and counterparties in B2C and B2B markets through products, infrastructure, services or investment activity suited to its sector.

Acquisitions by IHH Healthcare

IHH Healthcare has acquired 10 companies to date.

Last acquisition by IHH Healthcare was on September 4th 2024. IHH Healthcare acquired Island Hospital for $862M (EV/Revenue multiple available to Pro users).

See M&A valuation multiples

Latest Acquisitions by IHH Healthcare

Island Hospital
Bedrock Healthcare
Prince Court Medical Centre
Amanjaya Specialist Centre
Description
Island Hospital is a Penang-based multispecialty healthcare provider offering diagnostics, surgery, and oncology services. Equipped with 1.5 Tesla MRI scanners, PET-CT units, and robotic surgery systems, it treats cardiology, orthopedics, and fertility cases. The 600-bed facility serves Malaysia and international patients from Indonesia and the Middle East, accredited by MSQH and JCI standards.
Bedrock Healthcare was the Malaysian holding company that owned Timberland Medical Centre in Kuching, Sarawak. Timberland is a private multidisciplinary hospital serving patients in Kuching and the wider state through inpatient, outpatient, surgical and diagnostic care. At the time of acquisition, the operating hospital had 82 licensed beds and plans for a separate 200-bed facility on an acquired development site. Patients, insurers and corporate health programs fund the hospital's clinical services. Revenue comes from treatment, procedures, consultations, diagnostics and related care. IHH acquired Bedrock to establish a larger presence in East Malaysia and integrate Timberland into its nationwide hospital network. Bedrock Healthcare serves B2C and B2B customers through activities spanning Hospitals & Clinics and Medical Imaging & Diagnostics.
Prince Court Medical Centre is a private tertiary hospital in central Kuala Lumpur, Malaysia. It offers specialist inpatient and outpatient care across areas including surgery, oncology, cardiology, orthopaedics, women's health and diagnostic medicine. Local and international patients, insurers and corporate health programs pay for clinical services delivered by its physicians and hospital teams. Revenue is generated from hospital treatment, procedures, consultations, diagnostics and related patient services. Khazanah acquired the hospital from Petronas in 2018 and subsequently sold it to its controlled IHH Healthcare platform. Under IHH ownership, Prince Court operates as a premium hospital alongside the group's Pantai and Gleneagles brands in Malaysia.
Amanjaya Specialist Centre was a private multidisciplinary hospital in Sungai Petani, Kedah, Malaysia. At acquisition it operated 98 beds and provided medical, surgical, diagnostic and specialist services to patients in northern Peninsular Malaysia. Patients and insurers paid for inpatient, outpatient and ancillary clinical care delivered by the hospital and its doctors. The facility extended IHH's Pantai hospital network into a growing secondary city and complemented its existing presence in the region. After IHH acquired the company, the hospital was integrated into Parkway Pantai and later rebranded as Pantai Hospital Laguna Merbok. It remains an operating acute-care hospital within IHH's Malaysian portfolio. Amanjaya Specialist Centre serves B2C customers through activities spanning Hospitals & Clinics and Medical Imaging & Diagnostics.
HQ CountryMalaysiaMalaysiaMalaysiaMalaysia
HQ City
Penang
Kuching
Kuala Lumpur
Sungai Petani
Deal Date4 Sep 202429 Feb 20241 Sep 20201 Oct 2018
Valuation$862M$58M$245M$24M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all IHH Healthcare acquisitions and their M&A valuation multiples.

Start Free Trial

Investments by IHH Healthcare

IHH Healthcare has invested in 6 companies to date.

Latest investment by IHH Healthcare was on January 29th 2026. IHH Healthcare invested in TibaRay in their Strategic investment round.

See VC round multiples

Latest Investments by IHH Healthcare

TibaRay
Acibadem City Clinic
Gleneagles Global Hospitals
Doctor Anywhere
Description
TibaRay creates ultra-fast, precise technologies to improve cancer diagnosis and treatment accuracy.
Acibadem City Clinic is a Bulgarian private healthcare network created by combining Tokuda Group with City Clinic's hospitals and outpatient centres. It provides acute hospital care, oncology, cardiovascular treatment, diagnostics and specialist outpatient services across several Bulgarian facilities. Patients, insurers and the public reimbursement system pay for clinical services delivered by its medical teams. Revenue comes from hospital admissions, procedures, consultations, diagnostics and related care. The network is held through Acibadem City Clinic B.V. and operates as part of IHH Healthcare's Acibadem regional platform. IHH increased its effective ownership in 2023 by purchasing the International Finance Corporation's minority interest in the holding company. Acibadem City Clinic serves B2C and B2B customers through activities spanning Hospitals & Clinics and Medical Imaging & Diagnostics.
Gleneagles Healthcare India is an Indian private hospital network formerly known as Global Hospitals and Gleneagles Global Hospitals. It operates multi-specialty hospitals offering complex surgery, transplantation, oncology, gastroenterology, neurosciences and other tertiary-care services. Patients, insurers and corporate health programs purchase inpatient, outpatient, diagnostic and procedural care across its facilities. Revenue is earned from hospital treatment and associated clinical services in major Indian cities. IHH first acquired control through Parkway Pantai and later increased its holding through purchases from minority shareholders. The business now operates under the Gleneagles Hospitals brand as a substantially owned component of IHH's Indian healthcare portfolio.
Doctor Anywhere is a Singapore-headquartered telehealth provider delivering video consultations, medicine delivery, and chronic care plans across Southeast Asia. The app connects users to GPs in Singapore, Malaysia, and Thailand for 24/7 access. Founded in 2017, it partners with clinics like Fullerton Health.
HQ CountryUnited StatesBulgariaIndiaSingapore
HQ City
-
Sofia
Hyderabad
Singapore
Deal Date29 Jan 202619 Dec 202325 Sep 202321 Dec 2022
RoundStrategic investmentSecondarySecondarySeries C
Raisedundisclosedundisclosedundisclosed$39M
InvestorsIHH HealthcareIHH HealthcareIHH HealthcareAsia Partners Fund Management; Novo Holdings; IHH Healthcare; Square Peg Capital; OSK-SBI Venture Partners; EDBI; Kamet Capital Partners
Valuationundisclosed$65M$89Mundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all IHH Healthcare investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About IHH Healthcare

When was IHH Healthcare founded?IHH Healthcare was founded in 2010.
Where is IHH Healthcare headquartered?IHH Healthcare is headquartered in Malaysia.
How many employees does IHH Healthcare have?As of today, IHH Healthcare has over 70K employees.
Is IHH Healthcare publicly listed?Yes, IHH Healthcare is a public company listed on Bursa Malaysia.
What is the stock symbol of IHH Healthcare?IHH Healthcare trades under 5225 ticker.
When did IHH Healthcare go public?IHH Healthcare went public in 2012.
Who are competitors of IHH Healthcare?IHH Healthcare main competitors include Rede D'Or São Luiz, Dr. Sulaiman Al Habib, Tenet Healthcare, Encompass Health, Apollo Hospitals, DaVita, Aier EYE Hospital Group, Universal Health Services, Bradsaúde, Bangkok Dusit Medical Services.
What is the current market cap of IHH Healthcare?IHH Healthcare's current market cap is $17B.
What is the current revenue of IHH Healthcare?IHH Healthcare's last 12 months revenue is $6.9B.
What is the current revenue growth of IHH Healthcare?IHH Healthcare revenue growth (NTM/LTM) is 9%.
What is the current EV/Revenue multiple of IHH Healthcare?Current revenue multiple of IHH Healthcare is 3.1x.
What is the current EBITDA of IHH Healthcare?IHH Healthcare's last 12 months EBITDA is $1.5B.
What is IHH Healthcare's EBITDA margin?IHH Healthcare's last 12 months EBITDA margin is 22%.
What is the current EV/EBITDA multiple of IHH Healthcare?Current EBITDA multiple of IHH Healthcare is 14.0x.
What is the current FCF of IHH Healthcare?IHH Healthcare's last 12 months FCF is $781M.
What is IHH Healthcare's FCF margin?IHH Healthcare's last 12 months FCF margin is 11%.
What is the current EV/FCF multiple of IHH Healthcare?Current FCF multiple of IHH Healthcare is 27.3x.
How many companies IHH Healthcare has acquired to date?As of October 2026, IHH Healthcare has acquired 10 companies.
What was the largest acquisition by IHH Healthcare?$862M acquisition of Island Hospital on 4th September 2024 was the largest M&A IHH Healthcare has done to date.
What companies IHH Healthcare acquired?IHH Healthcare acquired Island Hospital, Prince Court Medical Centre, Gleneagles Global Hospitals, Fortis Healthcare, Continental Hospitals, Tokuda Group, Bedrock Healthcare, Amanjaya Specialist Centre, Angsana Molecular & Diagnostics Laboratory, and City Clinic Group.
In how many companies IHH Healthcare has invested to date?As of October 2026, IHH Healthcare has invested in 6 companies.
What was the last IHH Healthcare investment?On 29th January 2026 IHH Healthcare invested in TibaRay, participating in a Strategic investment round.
In what companies IHH Healthcare invested in?IHH Healthcare invested in Doctor Anywhere, Lucence Health, Us2.ai, Acibadem City Clinic, Gleneagles Global Hospitals, and TibaRay.

See public comps similar to IHH Healthcare

Lists including IHH Healthcare

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial